Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain

References

• Instituto Nacional de Estadística. Avance del Padrón Municipal a 1 de enero 2011. Madrid: INE; 2011 [Internet]. [cited 2011 Dec 12]. Available from: http://www.ine.es/prensa/np648.pdf
   Google Scholar
• Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010;115:22–7.
   PubMed Web of Science ®Google Scholar
• Schmunis GA. Yadon ZE. Chagas disease, a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14–21.
   PubMed Web of Science ®Google Scholar
• Jackson Y, Angheben A, Carrilero Fernandez B, Jansa i Lopez del Vallado JM, Jannin JG, Albajar-Viñas P. Management of Chagas disease in Europe. Experiences and challenges in Spain, Switzerland and Italy. Bull Soc Pathol Exot. 2009;102:326–9.
   PubMedGoogle Scholar
• Muñoz J, Gómez i Prat J, Gállego M, Gimeno F, Treviño B, López-Chejade P, et al.. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop. 2009;111:51–5.
   PubMed Web of Science ®Google Scholar
• Jackson Y, Alirol E, Getaz L, Wolff H, Combescure C, Chappuis F. Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis. 2010;5:e69–75.
   Google Scholar
• Murcia L, Carrilero B, Muñoz MJ, Iborra MA, Segovia M. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas’ disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother. 2010;65:1759–64.
   PubMed Web of Science ®Google Scholar
• Pérez-Ayala A, Pérez-Molina JA, Norman F, Navarro M, Monge-Maillo B, Díaz-Menéndez M, et al.. Chagas disease in Latin American migrants: a Spanish challenge. Clin Microbiol Infect. 2011;17:1108–13.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística. Revisión del padrón municipal 2010. Datos por municipios. 03-Alicante/Alacant. Población nacida en el extranjero por sexo, municipios y lugar de nacimiento. Madrid: INE; 2010 [cited 2011 Dec 29]. Available from: http://www.ine.es/jaxi/tabla.do?path = /t20/e245/p05/a2010/l0/&file = 00003004.px&type = pcaxis&L = 0
   Google Scholar
• Organización Panamericana de la Salud. Estimación cuantitativa de la enfermedad de Chagas en las Américas. Montevideo, Uruguay, Organización Panamericana de la Salud. Washington DC: PAHO Publishing; 2006. 1–28 [OPS/HDM/CD/425-06].
   Google Scholar
• WHO — World Health Organization. Control of Chagas Disease, WHO Technical Report Series 811. Geneva: WHO; 2002. [cited 2010 May 01]. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_905.pdf
   Google Scholar
• Flores-Chávez M, Fernández B, Puente S, Torres P, Rodríguez M, Monedero C, et al.. Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis. 2008;46:e44–7.
   PubMed Web of Science ®Google Scholar
• Gascón J, Albajar P, Cañas E, Flores M, Gómez i Prat J, Herrera RN, et al.. Diagnosis, management and treatment of chronic Chagas’ heart disease in areas where Trypanosoma cruzi infection is not endemic. Rev Esp Cardiol. 2007;60:285–93.
   PubMed Web of Science ®Google Scholar
• Sosa-Estani S, Viotti R, Segura EL. Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz. 2009;104 Suppl 1:167–80.
   PubMed Web of Science ®Google Scholar
• de Oliveira RB, Troncon LE, Dantas R, Menghelli UG. Gastrointestinal manifestations of Chagas' disease. Am J Gastroenterol. 1998;93:884–9.
   PubMed Web of Science ®Google Scholar
• Muñoz J, Coll O, Juncosa T, Vergés M, Vergés M, del Pino M, Fumado V, et al.. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis. 2009;48:1736–40.
   PubMed Web of Science ®Google Scholar
• Ramos JM, Milla A, Sánchez V, Vergés M, Toro C, Gutiérrez F. Prenatal screening for Trypanosoma cruzi and human T lymphotropic virus types 1 and 2 in pregnant Latin American women. Enferm Infecc Microbiol Clin. 1999;27:165–7.
   Google Scholar
• Ramos JM, Ponce Y, Gallegos I, Flores-Chávez M, Cañavate C, Gutiérrez F. Trypanosoma cruzi infection in Elche (Spain): comparison of the seroprevalence in immigrants from Paraguay and Bolivia. Pathog Glob Health. 2012;106:102–6.
   PubMed Web of Science ®Google Scholar
• Garcia-Alvarez A, Sitges M, Pinazo MJ, Regueiro-Cueva A, Posada E, Poyatos S, et al.. Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS Negl Trop Dis. 2010;21;4 pii:e826.
   Web of Science ®Google Scholar
• Pérez-Ayala A, Pérez-Molina JA, Norman F, Monge-Maillo B, Faro MV, López-Vélez R. Gastro-intestinal Chagas disease in migrants to Spain: prevalence and methods for early diagnosis. Ann Trop Med Parasitol. 2011;105:25–9.
   PubMed Web of Science ®Google Scholar
• Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, et al.. BENEFIT Investigators. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas’ cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J. 2008;156:37–43.
   PubMed Web of Science ®Google Scholar
• Pérez-Molina JA, Pérez-Ayala A, Moreno S, Fernández-González MC, Zamora J, López-Velez R. Use of benznidazole to treat chronic Chagas’ disease: a systematic review with a meta-analysis. J Antimicrob Chemother. 2009;64:1139–47.
   PubMed Web of Science ®Google Scholar
• Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, et al.. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med. 2006;144:724–34.
   PubMed Web of Science ®Google Scholar
• Pinazo MJ, Muñoz J, Posada E, López-Chejade P, Gállego M, Ayala E, et al.. Tolerance of benznidazole in treatment of Chagas' disease in adults. Antimicrob Agents Chemother. 2010;54:4896–9.
   PubMed Web of Science ®Google Scholar
• Gomes YM, Lorena VM, Luquetti AO. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem Inst Oswaldo Cruz. 2009;104 (Suppl 1):115–21.
   PubMedGoogle Scholar
• Carrilero B, Murcia L, Martínez-Lage L, Segovia M. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country. Rev Esp Quimioter. 2011;24:123–6.
   PubMed Web of Science ®Google Scholar
• Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, et al.. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev Anti Infect Ther. 2009;7:157–63.
   PubMed Web of Science ®Google Scholar